drugset / Trial / NCT05450770
Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever Vaccination
Not yet recruiting
60 enrolled
ANRS, Emerging Infectious Diseases
Bichat Hospital · collabHôpital Cochin · collabSaint-Louis Hospital, Paris, France · collab
Non-randomizedParallel-groupOpen-labelPrevention
Summary
ANRS 0146s NovaaTen study aims to determine the vaccine responses in the participants of the ANRS EP46 Novaa trial 10 years after a primary anti-yellow fever vaccination
Timeline
- Start
- 2024-11-01
- Primary completion
- 2024-11-01
- Completion
- 2024-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Yellow Fever Vaccine | Vaccine | — | — |